康希诺生物 CanSinoBIO

Keywords you search：

1 Monthly Return of Equity Issuer on Movements in Securities

Description
2 DISCLOSEABLE TRANSACTION PURCHASE OF STRUCTURED DEPOSIT

Description
3 NOTICE OF BOARD MEETING

Description
4 VOLUNTARY ANNOUNCEMENT POSITIVE PRELIMINARY PHASE I CLINICAL RESULTS FOR PROTEIN-BASED PNEUMOCOCCAL VACCINE

Description
5 VOLUNTARY ANNOUNCEMENT HAEMOPHILUS INFLUENZAE TYPE B CONJUGATE VACCINE, FREEZE-DRIED OBTAINS CLINICAL TRIAL APPROVAL

Description
6 2023 Annual Report

Description
7 2023 Environmental, Social and Governance & Corporate Social Responsibility Report

Description
8 FIRST QUARTERLY REPORT FOR THE THREE MONTHS ENDED MARCH 31, 2024

Description
9 Monthly Return of Equity Issuer on Movements in Securities

Description
10 DISCLOSEABLE TRANSACTION PURCHASE OF STRUCTURED DEPOSIT

Description

First Page Pre. Page Current Page(59) Next Page End Page(62)